SLE--a disease of clearance deficiency?
Systemic lupus erythematosus (SLE) is a multifactorial disease and its pathogenesis and precise aetiology remain unknown. Under physiological conditions, neither apoptotic nor necrotic cell material is easily found in tissues because of its quick removal by a highly efficient scavenger system. Autoantigens are found in apoptotic and necrotic material and they are recognized by autoimmune sera from SLE patients. The clearance of dying cells is finely regulated by a highly redundant system of receptors on phagocytic cells and bridging molecules, which detect molecules specific for dying cells. Changes on apoptotic and necrotic cell surfaces are extremely important for their recognition and further disposal. Some SLE patients seem to have an impaired ability to clear such apoptotic material from tissues, and this could cause the breakdown of central and peripheral mechanisms of tolerance against self-antigens. In this article, we address the cells, receptors and molecules involved in the clearance process and show how deficiencies in this process may contribute to the aetiopathogenesis of SLE.
Munoz
L E
LE
Institute for Clinical Immunology, Friedrich-Alexander University of Erlangen-Nuremberg, Germany.
Gaipl
U S
US
Franz
S
S
Sheriff
A
A
Voll
R E
RE
Kalden
J R
JR
Herrmann
Martin
M
D017209:Apoptosis / Q000276:immunology; D001324:Autoantigens / Q000276:immunology; D015551:Autoimmunity; D006801:Humans; D007108:Immune Tolerance; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D010587:Phagocytosis / Q000276:immunology*
D001324:Autoantigens